Literature DB >> 25434510

[Treatment of tuberculosis].

J Ben Amar1, B Dhahri2, H Aouina2, S Azzabi2, M A Baccar2, L El Gharbi2, H Bouacha2.   

Abstract

The aim of this article is to give practicing physicians a practical approach to the treatment of latent and active tuberculosis. Most patients follow TB standard treatment recommended by WHO that depend on category of patient. It is a combination of four essential tuberculosis drugs of the first group: isoniazid, rifampicin, pyrazinamid and ethambutol; in some cases streptomycin can replace ethambutol. This initial phase of intensive treatment is followed by a consolidation phase. Drugs should be administered in the morning on an empty stomach one hour before meals. Treatment of latent tuberculosis (TB) infection is an important component of TB control programs. Preventive treatment can reduce the risk of developing active TB.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Latent tuberculosis; Traitement; Treatment; Tuberculose; Tuberculose latente; Tuberculosis

Mesh:

Substances:

Year:  2014        PMID: 25434510     DOI: 10.1016/j.pneumo.2014.09.001

Source DB:  PubMed          Journal:  Rev Pneumol Clin        ISSN: 0761-8417


  3 in total

1.  PARP-1-modulated AIF translocation is involved in streptomycin-induced cochlear hair cell death.

Authors:  Yongdong Song; Zhaomin Fan; Xiaohui Bai; Wenwen Liu; Yuechen Han; Lei Xu; Mingming Wang; Jianfeng Li; Qingyin Zheng; Daogong Zhang; Haibo Wang
Journal:  Acta Otolaryngol       Date:  2016-03-10       Impact factor: 1.494

2.  Effect of Health Education Combined with Dietary Guidance on Nutritional Indicator, Immune Level, and Quality of Life of Patients with Pulmonary Tuberculosis.

Authors:  Baojuan Hu; Guoxia Ren; Lin Zhao
Journal:  Comput Math Methods Med       Date:  2021-09-29       Impact factor: 2.238

3.  Noncontiguous multi-tiered spinal tuberculosis associated with sternal localization: a case report.

Authors:  Mariam Erraoui; Bouchra Amine; Latifa Tahiri; Imane El Binoune; Jihane Bahha; Najia Hajjaj-Hassouni
Journal:  J Med Case Rep       Date:  2017-07-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.